These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12008913)

  • 1. Delivery of dangerous goods: type III secretion in enteric pathogens.
    Zaharik ML; Gruenheid S; Perrin AJ; Finlay BB
    Int J Med Microbiol; 2002 Mar; 291(8):593-603. PubMed ID: 12008913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.
    Hayward RD; Cain RJ; McGhie EJ; Phillips N; Garner MJ; Koronakis V
    Mol Microbiol; 2005 May; 56(3):590-603. PubMed ID: 15819617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella type III secretion effectors: pulling the host cell's strings.
    Schlumberger MC; Hardt WD
    Curr Opin Microbiol; 2006 Feb; 9(1):46-54. PubMed ID: 16406778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
    Pinaud L; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
    Parsot C
    FEMS Microbiol Lett; 2005 Nov; 252(1):11-8. PubMed ID: 16182469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia's stratagem: targeting innate and adaptive immune defense.
    Heesemann J; Sing A; Trülzsch K
    Curr Opin Microbiol; 2006 Feb; 9(1):55-61. PubMed ID: 16413818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III secretion machines and the pathogenesis of enteric infections caused by Yersinia and Salmonella spp.
    Lee VT; Schneewind O
    Immunol Rev; 1999 Apr; 168():241-55. PubMed ID: 10399078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive enteric pathogens.
    Formal SB; Hale TL; Sansonetti PJ
    Rev Infect Dis; 1983; 5 Suppl 4():S702-7. PubMed ID: 6356290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subtherapeutic concentrations of antimicrobials on gene acquisition events in Yersinia, Proteus, Shigella, and Salmonella recipient organisms in isolated ligated intestinal loops of swine.
    Brewer MT; Xiong N; Anderson KL; Carlson SA
    Am J Vet Res; 2013 Aug; 74(8):1078-83. PubMed ID: 23879845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.
    Lin S; Zhang Z; Xu H; Li L; Chen S; Li J; Hao Z; Chen PR
    J Am Chem Soc; 2011 Dec; 133(50):20581-7. PubMed ID: 22084898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of bacterial internalization counteracted by Yersinia.
    Fällman M; Gustavsson A
    Int Rev Cytol; 2005; 246():135-88. PubMed ID: 16164968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
    Crane JK; Majumdar S; Pickhardt DF
    Infect Immun; 1999 May; 67(5):2575-84. PubMed ID: 10225923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type iii protein secretion in yersinia species.
    Ramamurthi KS; Schneewind O
    Annu Rev Cell Dev Biol; 2002; 18():107-33. PubMed ID: 12142275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of human gastrointestinal tract bacterial pathogens on host cell apoptosis].
    Wronowska W; Godlewska R; Jagusztyn-Krynicka EK
    Postepy Biochem; 2005; 51(3):270-9. PubMed ID: 16381171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical functions of Yersinia type III effectors.
    Shao F
    Curr Opin Microbiol; 2008 Feb; 11(1):21-9. PubMed ID: 18299249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella and Enteroinvasive Escherichia Coli.
    Belotserkovsky I; Sansonetti PJ
    Curr Top Microbiol Immunol; 2018; 416():1-26. PubMed ID: 30218158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular evolutionary history of Shigella spp. and enteroinvasive Escherichia coli.
    Peng J; Yang J; Jin Q
    Infect Genet Evol; 2009 Jan; 9(1):147-52. PubMed ID: 19000785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteropathogenic Escherichia coli (EPEC) Tir receptor molecule does not undergo full modification when introduced into host cells by EPEC-independent mechanisms.
    Kenny B; Warawa J
    Infect Immun; 2001 Mar; 69(3):1444-53. PubMed ID: 11179311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella and Shigella species.
    Edwards BH
    Clin Lab Med; 1999 Sep; 19(3):469-87, v. PubMed ID: 10549421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.